Analysis | Metabolite Name | Measured Value | Units | Genotype | Intestinal Segment |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 1009 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 3260 | Peak area | FLOX | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 3298 | Peak area | FLOX | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 8142 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 8228 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 13911 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 16164 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 16495 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 17791 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 19027 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 27657 | Peak area | FLOX | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 28135 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 30813 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 31181 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 31475 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 36474 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 48310 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 53392 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 54088 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 54262 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 56807 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 60746 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 62121 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 63631 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 65458 | Peak area | FLOX | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 69158 | Peak area | FLOX | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 73397 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 80859 | Peak area | FLOX | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 86448 | Peak area | Knockout | Jejunum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 110086 | Peak area | FLOX | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 119400 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 163371 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 181791 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 233738 | Peak area | FLOX | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 340245 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 428573 | Peak area | Knockout | Illeum |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | FLOX | Duodenum | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | FLOX | Illeum | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | FLOX | Jejunum | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | Knockout | Duodenum | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | Knockout | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | 1887 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | FLOX | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | FLOX | Illeum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | FLOX | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | Knockout | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | Knockout | Illeum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O] | Peak area | Knockout | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | 1634 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | 4651 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | 5945 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | FLOX | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | FLOX | Illeum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | FLOX | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | Knockout | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | Knockout | Illeum | |
Reversed phase POSITIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+ | Peak area | Knockout | Jejunum |